{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:27:54Z","timestamp":1789471674025,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2019-1482"],"award-info":[{"award-number":["2019-1482"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2021 ID 25788"],"award-info":[{"award-number":["IG 2021 ID 25788"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Research National Research","award":["PRIN 2017, protocol number 2017ZFJCS3"],"award-info":[{"award-number":["PRIN 2017, protocol number 2017ZFJCS3"]}]},{"name":"Thompson Family Foundation Initiative at Columbia University","award":["GT005845"],"award-info":[{"award-number":["GT005845"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70294-w","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:03:12Z","timestamp":1724166192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation"],"prefix":"10.1038","volume":"14","author":[{"given":"Irina","family":"Utkina-Sosunova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangels","family":"de Planell-Saguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Alda","family":"Carozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Canta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Monza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Karan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Moayedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Przedborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Cavaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"70294_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246088","author":"P Alberti","year":"2022","unstructured":"Alberti, P. et al. Neurological complications of conventional and novel anticancer treatments. Cancers https:\/\/doi.org\/10.3390\/cancers14246088 (2022).","journal-title":"Cancers"},{"key":"70294_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/pmt.15.19","volume":"5","author":"JA Boyette-Davis","year":"2015","unstructured":"Boyette-Davis, J. A., Walters, E. T. & Dougherty, P. M. Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag. 5, 285\u2013296. https:\/\/doi.org\/10.2217\/pmt.15.19 (2015).","journal-title":"Pain Manag."},{"key":"70294_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","volume":"28","author":"G Cavaletti","year":"2015","unstructured":"Cavaletti, G. & Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol 28, 500\u2013507. https:\/\/doi.org\/10.1097\/WCO.0000000000000234 (2015).","journal-title":"Curr Opin Neurol"},{"key":"70294_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11060-017-2389-9","volume":"132","author":"ZA Corbin","year":"2017","unstructured":"Corbin, Z. A. et al. Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of mycosis fungoides and sezary syndrome. J. Neurooncol. 132, 439\u2013446. https:\/\/doi.org\/10.1007\/s11060-017-2389-9 (2017).","journal-title":"J. Neurooncol."},{"key":"70294_CR5","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1007\/s00520-012-1384-0","volume":"20","author":"LT Vahdat","year":"2012","unstructured":"Vahdat, L. T. et al. Ixabepilone-associated peripheral neuropathy: Data from across the phase II and III clinical trials. Supp. Care Cancer 20, 2661\u20132668. https:\/\/doi.org\/10.1007\/s00520-012-1384-0 (2012).","journal-title":"Supp. Care Cancer"},{"key":"70294_CR6","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","volume":"34","author":"DL Hershman","year":"2016","unstructured":"Hershman, D. L. et al. Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials. J. Clin. Oncol. 34, 3014\u20133022. https:\/\/doi.org\/10.1200\/JCO.2015.66.2346 (2016).","journal-title":"J. Clin. Oncol."},{"key":"70294_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jns.12306","volume":"24","author":"G Cavaletti","year":"2019","unstructured":"Cavaletti, G. et al. Patients\u2019 and physicians\u2019 interpretation of chemotherapy-induced peripheral neurotoxicity. J. Peripher. Nerv. Syst. 24, 111\u2013119. https:\/\/doi.org\/10.1111\/jns.12306 (2019).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"70294_CR8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny, M. et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain 155, 2461\u20132470. https:\/\/doi.org\/10.1016\/j.pain.2014.09.020 (2014).","journal-title":"Pain"},{"key":"70294_CR9","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","volume":"33","author":"DR Pachman","year":"2015","unstructured":"Pachman, D. R. et al. Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (alliance). J. Clin. Oncol. 33, 3416\u20133422. https:\/\/doi.org\/10.1200\/JCO.2014.58.8533 (2015).","journal-title":"J. Clin. Oncol."},{"key":"70294_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3322\/caac.21204","volume":"63","author":"SB Park","year":"2013","unstructured":"Park, S. B. et al. Chemotherapy-induced peripheral neurotoxicity: A critical analysis. CA Cancer J. Clin. 63, 419\u2013437. https:\/\/doi.org\/10.3322\/caac.21204 (2013).","journal-title":"CA Cancer J. Clin."},{"key":"70294_CR11","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi, C. L. et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J. Clin. Oncol. 38, 3325\u20133348. https:\/\/doi.org\/10.1200\/JCO.20.01399 (2020).","journal-title":"J. Clin. Oncol."},{"key":"70294_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz011","author":"SG Dorsey","year":"2019","unstructured":"Dorsey, S. G. et al. NCI clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J. Natl. Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djz011 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"70294_CR13","first-page":"2416","volume":"6","author":"E Mora","year":"2016","unstructured":"Mora, E., Smith, E. M., Donohoe, C. & Hertz, D. L. Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am. J. Cancer Res. 6, 2416\u20132430 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"70294_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/PEP.0000000000000208","volume":"28","author":"L Gilchrist","year":"2016","unstructured":"Gilchrist, L. & Tanner, L. Gait patterns in children with cancer and vincristine neuropathy. Pediatr. Phys. Ther. 28, 16\u201322. https:\/\/doi.org\/10.1097\/PEP.0000000000000208 (2016).","journal-title":"Pediatr. Phys. Ther."},{"issue":"Suppl 2","key":"70294_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1111\/jns.12334","volume":"24","author":"B Islam","year":"2019","unstructured":"Islam, B. et al. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment. J. Peripher. Nerv. Syst. 24(Suppl 2), S63\u2013S73. https:\/\/doi.org\/10.1111\/jns.12334 (2019).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"70294_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00520-016-3404-y","volume":"25","author":"JM Schloss","year":"2017","unstructured":"Schloss, J. M. et al. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Supp. Care Cancer 25, 195\u2013204. https:\/\/doi.org\/10.1007\/s00520-016-3404-y (2017).","journal-title":"Supp. Care Cancer"},{"key":"70294_CR17","first-page":"2601","volume":"29","author":"AL Kautio","year":"2009","unstructured":"Kautio, A. L. et al. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. Anticancer Res. 29, 2601\u20132606 (2009).","journal-title":"Anticancer Res."},{"key":"70294_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/pbc.25384","volume":"62","author":"SM Bradfield","year":"2015","unstructured":"Bradfield, S. M., Sandler, E., Geller, T., Tamura, R. N. & Krischer, J. P. Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Pediatr. Blood Cancer 62, 1004\u20131010. https:\/\/doi.org\/10.1002\/pbc.25384 (2015).","journal-title":"Pediatr. Blood Cancer"},{"key":"70294_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00520-015-3063-4","volume":"24","author":"N Majithia","year":"2016","unstructured":"Majithia, N. et al. National cancer institute-supported chemotherapy-induced peripheral neuropathy trials: Outcomes and lessons. Support Care Cancer 24, 1439\u20131447. https:\/\/doi.org\/10.1007\/s00520-015-3063-4 (2016).","journal-title":"Support Care Cancer"},{"key":"70294_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fncel.2016.00179","volume":"10","author":"GW Berbusse","year":"2016","unstructured":"Berbusse, G. W., Woods, L. C., Vohra, B. P. & Naylor, K. Mitochondrial dynamics decrease prior to axon degeneration induced by vincristine and are partially rescued by overexpressed cytNmnat1. Front. Cell. Neurosci. 10, 179. https:\/\/doi.org\/10.3389\/fncel.2016.00179 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"70294_CR21","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/brain\/aww251","volume":"139","author":"S Geisler","year":"2016","unstructured":"Geisler, S. et al. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain J. Neurol. 139, 3092\u20133108. https:\/\/doi.org\/10.1093\/brain\/aww251 (2016).","journal-title":"Brain J. Neurol."},{"key":"70294_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060733","volume":"8","author":"XT Ji","year":"2013","unstructured":"Ji, X. T. et al. Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model. PLoS One 8, e60733. https:\/\/doi.org\/10.1371\/journal.pone.0060733 (2013).","journal-title":"PLoS One"},{"key":"70294_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12974-018-1116-6","volume":"15","author":"K Montague","year":"2018","unstructured":"Montague, K., Simeoli, R., Valente, J. & Malcangio, M. A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain. J. Neuroinflamm. 15, 101. https:\/\/doi.org\/10.1186\/s12974-018-1116-6 (2018).","journal-title":"J. Neuroinflamm."},{"key":"70294_CR24","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1172\/JCI71389","volume":"124","author":"EA Old","year":"2014","unstructured":"Old, E. A. et al. Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain. J. Clin. Invest. 124, 2023\u20132036. https:\/\/doi.org\/10.1172\/JCI71389 (2014).","journal-title":"J. Clin. Invest."},{"key":"70294_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nbd.2015.04.012","volume":"79","author":"Y Shen","year":"2015","unstructured":"Shen, Y. et al. Exogenous induction of HO-1 alleviates vincristine-induced neuropathic pain by reducing spinal glial activation in mice. Neurobiol. Dis. 79, 100\u2013110. https:\/\/doi.org\/10.1016\/j.nbd.2015.04.012 (2015).","journal-title":"Neurobiol. Dis."},{"key":"70294_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2017.11.011","volume":"111","author":"L Van Helleputte","year":"2018","unstructured":"Van Helleputte, L. et al. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiol. Dis. 111, 59\u201369. https:\/\/doi.org\/10.1016\/j.nbd.2017.11.011 (2018).","journal-title":"Neurobiol. Dis."},{"key":"70294_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuropharm.2018.03.004","volume":"135","author":"L Zhou","year":"2018","unstructured":"Zhou, L. et al. Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1\/CXCR2 signaling pathway. Neuropharmacology 135, 34\u201347. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.004 (2018).","journal-title":"Neuropharmacology"},{"key":"70294_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tcb.2014.04.003","volume":"24","author":"LJ Neukomm","year":"2014","unstructured":"Neukomm, L. J. & Freeman, M. R. Diverse cellular and molecular modes of axon degeneration. Trends Cell. Biol. 24, 515\u2013523. https:\/\/doi.org\/10.1016\/j.tcb.2014.04.003 (2014).","journal-title":"Trends Cell. Biol."},{"key":"70294_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrn3680","volume":"15","author":"L Conforti","year":"2014","unstructured":"Conforti, L., Gilley, J. & Coleman, M. P. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat. Rev. Neurosci. 15, 394\u2013409. https:\/\/doi.org\/10.1038\/nrn3680 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"70294_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129920","author":"S Geisler","year":"2019","unstructured":"Geisler, S. et al. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.129920 (2019).","journal-title":"JCI Insight"},{"key":"70294_CR31","doi-asserted-by":"publisher","first-page":"10654","DOI":"10.1073\/pnas.1809392115","volume":"115","author":"HW Liu","year":"2018","unstructured":"Liu, H. W. et al. Pharmacological bypass of NAD(+) salvage pathway protects neurons from chemotherapy-induced degeneration. Proc. Natl. Acad. Sci. USA 115, 10654\u201310659. https:\/\/doi.org\/10.1073\/pnas.1809392115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70294_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jns.12219","volume":"22","author":"E Turkiew","year":"2017","unstructured":"Turkiew, E., Falconer, D., Reed, N. & Hoke, A. Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy. J. Peripher. Nerv. Syst. 22, 162\u2013171. https:\/\/doi.org\/10.1111\/jns.12219 (2017).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"70294_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.celrep.2016.06.013","volume":"16","author":"H Li","year":"2016","unstructured":"Li, H. et al. Protein prenylation constitutes an endogenous brake on axonal growth. Cell Rep. 16, 545\u2013558. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.013 (2016).","journal-title":"Cell Rep."},{"key":"70294_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.celrep.2016.06.087","volume":"16","author":"CM Simon","year":"2016","unstructured":"Simon, C. M. et al. A stem cell model of the motor circuit uncouples motor neuron death from hyperexcitability induced by SMN deficiency. Cell Rep. 16, 1416\u20131430. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.087 (2016).","journal-title":"Cell Rep."},{"key":"70294_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","volume":"110","author":"H Wichterle","year":"2002","unstructured":"Wichterle, H., Lieberam, I., Porter, J. A. & Jessell, T. M. Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385\u2013397 (2002).","journal-title":"Cell"},{"key":"70294_CR36","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1073\/pnas.0914351107","volume":"107","author":"H Hattori","year":"2010","unstructured":"Hattori, H. et al. Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. Proc. Natl. Acad. Sci. USA 107, 3546\u20133551. https:\/\/doi.org\/10.1073\/pnas.0914351107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70294_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.stem.2015.06.003","volume":"17","author":"X Li","year":"2015","unstructured":"Li, X. et al. Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 17, 195\u2013203. https:\/\/doi.org\/10.1016\/j.stem.2015.06.003 (2015).","journal-title":"Cell Stem Cell"},{"key":"70294_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.stem.2015.01.003","volume":"16","author":"C Yu","year":"2015","unstructured":"Yu, C. et al. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell 16, 142\u2013147. https:\/\/doi.org\/10.1016\/j.stem.2015.01.003 (2015).","journal-title":"Cell Stem Cell"},{"key":"70294_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/50645","author":"JM Posimo","year":"2014","unstructured":"Posimo, J. M. et al. Viability assays for cells in culture. J. Vis. Exp. https:\/\/doi.org\/10.3791\/50645 (2014).","journal-title":"J. Vis. Exp."},{"key":"70294_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67\u201373. https:\/\/doi.org\/10.1177\/108705719900400206 (1999).","journal-title":"J. Biomol. Screen"},{"key":"70294_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1087057106296498","volume":"12","author":"Y Sui","year":"2007","unstructured":"Sui, Y. & Wu, Z. Alternative statistical parameter for high-throughput screening assay quality assessment. J. Biomol. Screen 12, 229\u2013234. https:\/\/doi.org\/10.1177\/1087057106296498 (2007).","journal-title":"J. Biomol. Screen"},{"key":"70294_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.celrep.2015.06.019","volume":"12","author":"B Ikiz","year":"2015","unstructured":"Ikiz, B. et al. The regulatory machinery of neurodegeneration in in vitro models of amyotrophic lateral sclerosis. Cell Rep. 12, 335\u2013345. https:\/\/doi.org\/10.1016\/j.celrep.2015.06.019 (2015).","journal-title":"Cell Rep."},{"key":"70294_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.neuron.2014.01.011","volume":"81","author":"DB Re","year":"2014","unstructured":"Re, D. B. et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 81, 1001\u20131008. https:\/\/doi.org\/10.1016\/j.neuron.2014.01.011 (2014).","journal-title":"Neuron"},{"key":"70294_CR44","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/s41598-020-60990-8","volume":"10","author":"AM Cirrincione","year":"2020","unstructured":"Cirrincione, A. M. et al. Paclitaxel-induced peripheral neuropathy is caused by epidermal ROS and mitochondrial damage through conserved MMP-13 activation. Sci. Rep. 10, 3970. https:\/\/doi.org\/10.1038\/s41598-020-60990-8 (2020).","journal-title":"Sci. Rep."},{"key":"70294_CR45","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/ncomms3179","volume":"4","author":"Z Tang","year":"2013","unstructured":"Tang, Z. et al. Pirt functions as an endogenous regulator of TRPM8. Nat. Commun. 4, 2179. https:\/\/doi.org\/10.1038\/ncomms3179 (2013).","journal-title":"Nat. Commun."},{"key":"70294_CR46","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1182\/blood-2011-02-336891","volume":"118","author":"M Kalac","year":"2011","unstructured":"Kalac, M. et al. HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. Blood 118, 5506\u20135516. https:\/\/doi.org\/10.1182\/blood-2011-02-336891 (2011).","journal-title":"Blood"},{"key":"70294_CR47","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/sj.leu.2404258","volume":"20","author":"T Palomero","year":"2006","unstructured":"Palomero, T. et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia 20, 1279\u20131287. https:\/\/doi.org\/10.1038\/sj.leu.2404258 (2006).","journal-title":"Leukemia"},{"key":"70294_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/hh0102.102330","volume":"90","author":"LJ Ignarro","year":"2002","unstructured":"Ignarro, L. J., Napoli, C. & Loscalzo, J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: An overview. Circ. Res 90, 21\u201328. https:\/\/doi.org\/10.1161\/hh0102.102330 (2002).","journal-title":"Circ. Res"},{"issue":"Suppl 11","key":"70294_CR49","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00005344-198914110-00004","volume":"14","author":"M Feelisch","year":"1989","unstructured":"Feelisch, M., Ostrowski, J. & Noack, E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14(Suppl 11), S13-22 (1989).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"70294_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00395-014-0421-1","volume":"109","author":"D Fraccarollo","year":"2014","unstructured":"Fraccarollo, D. et al. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition. Basic Res. Cardiol. 109, 421. https:\/\/doi.org\/10.1007\/s00395-014-0421-1 (2014).","journal-title":"Basic Res. Cardiol."},{"key":"70294_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.niox.2013.04.004","volume":"34","author":"T Sawa","year":"2013","unstructured":"Sawa, T. et al. Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide. Nitric Oxide 34, 10\u201318. https:\/\/doi.org\/10.1016\/j.niox.2013.04.004 (2013).","journal-title":"Nitric Oxide"},{"key":"70294_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","volume":"307","author":"C Meregalli","year":"2018","unstructured":"Meregalli, C. et al. Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy. Exp. Neurol. 307, 129\u2013132. https:\/\/doi.org\/10.1016\/j.expneurol.2018.06.005 (2018).","journal-title":"Exp. Neurol."},{"key":"70294_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4103\/0253-7613.190744","volume":"48","author":"N Minaz","year":"2016","unstructured":"Minaz, N. & Razdan, R. Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats. Indian J. Pharmacol. 48, 544\u2013549. https:\/\/doi.org\/10.4103\/0253-7613.190744 (2016).","journal-title":"Indian J. Pharmacol."},{"key":"70294_CR54","first-page":"337","volume":"31","author":"JM Fromson","year":"1981","unstructured":"Fromson, J. M. et al. Absorption and disposition of [14C]-molsidomine in laboratory animals. Arzneimittelforschung 31, 337\u2013345 (1981).","journal-title":"Arzneimittelforschung"},{"key":"70294_CR55","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0002-8703(85)90671-4","volume":"109","author":"T Meinertz","year":"1985","unstructured":"Meinertz, T. et al. Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans. Am. Heart J. 109, 644\u2013648 (1985).","journal-title":"Am. Heart J."},{"key":"70294_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0002-8703(85)90670-2","volume":"109","author":"J Ostrowski","year":"1985","unstructured":"Ostrowski, J. & Resag, K. Pharmacokinetics of molsidomine in humans. Am. Heart J. 109, 641\u2013643 (1985).","journal-title":"Am. Heart J."},{"key":"70294_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2165\/00003088-199630050-00004","volume":"30","author":"B Rosenkranz","year":"1996","unstructured":"Rosenkranz, B., Winkelmann, B. R. & Parnham, M. J. Clinical pharmacokinetics of molsidomine. Clin. Pharmacokinet. 30, 372\u2013384. https:\/\/doi.org\/10.2165\/00003088-199630050-00004 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"70294_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109323","volume":"363","author":"L Monza","year":"2021","unstructured":"Monza, L., Fumagalli, G., Chiorazzi, A. & Alberti, P. Translating morphology from bench side to bed side via neurophysiology: 8-min protocol for peripheral neuropathy research. J. Neurosci. Methods 363, 109323. https:\/\/doi.org\/10.1016\/j.jneumeth.2021.109323 (2021).","journal-title":"J. Neurosci. Methods"},{"key":"70294_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031058","author":"C Meregalli","year":"2021","unstructured":"Meregalli, C. et al. Human intravenous immunoglobulin alleviates neuropathic symptoms in a rat model of paclitaxel-induced peripheral neurotoxicity. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22031058 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"70294_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113140","volume":"326","author":"HC Lehmann","year":"2020","unstructured":"Lehmann, H. C., Staff, N. P. & Hoke, A. Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations. Exp. Neurol. 326, 113140. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113140 (2020).","journal-title":"Exp. Neurol."},{"key":"70294_CR61","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1523\/JNEUROSCI.2936-14.2015","volume":"35","author":"Y Rudhard","year":"2015","unstructured":"Rudhard, Y. et al. Identification of 12\/15-lipoxygenase as a regulator of axon degeneration through high-content screening. J. Neurosci. 35, 2927\u20132941. https:\/\/doi.org\/10.1523\/JNEUROSCI.2936-14.2015 (2015).","journal-title":"J. Neurosci."},{"key":"70294_CR62","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.pain.2013.02.023","volume":"154","author":"T Hara","year":"2013","unstructured":"Hara, T. et al. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain 154, 882\u2013889. https:\/\/doi.org\/10.1016\/j.pain.2013.02.023 (2013).","journal-title":"Pain"},{"key":"70294_CR63","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman, E. L., Nave, K. A., Jensen, T. S. & Bennett, D. L. H. New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron 93, 1296\u20131313. https:\/\/doi.org\/10.1016\/j.neuron.2017.02.005 (2017).","journal-title":"Neuron"},{"key":"70294_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biology10090849","author":"J Skubnik","year":"2021","unstructured":"Skubnik, J., Pavlickova, V. S., Ruml, T. & Rimpelova, S. Vincristine in combination therapy of cancer: Emerging trends in clinics. Biology https:\/\/doi.org\/10.3390\/biology10090849 (2021).","journal-title":"Biology"},{"key":"70294_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3959(02)00445-1","volume":"103","author":"HR Weng","year":"2003","unstructured":"Weng, H. R., Cordella, J. V. & Dougherty, P. M. Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103, 131\u2013138 (2003).","journal-title":"Pain"},{"key":"70294_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pain.2005.05.026","volume":"117","author":"J Kamei","year":"2005","unstructured":"Kamei, J., Tamura, N. & Saitoh, A. Possible involvement of the spinal nitric oxide\/cGMP pathway in vincristine-induced painful neuropathy in mice. Pain 117, 112\u2013120. https:\/\/doi.org\/10.1016\/j.pain.2005.05.026 (2005).","journal-title":"Pain"},{"key":"70294_CR67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.brainresbull.2006.05.008","volume":"70","author":"E Chung","year":"2006","unstructured":"Chung, E. et al. Dynorphin-mediated antinociceptive effects of L-arginine and SIN-1 (an NO donor) in mice. Brain Res. Bull. 70, 245\u2013250. https:\/\/doi.org\/10.1016\/j.brainresbull.2006.05.008 (2006).","journal-title":"Brain Res. Bull."},{"key":"70294_CR68","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0014-2999(90)90446-d","volume":"186","author":"ID Durate","year":"1990","unstructured":"Durate, I. D., Lorenzetti, B. B. & Ferreira, S. H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 186, 289\u2013293. https:\/\/doi.org\/10.1016\/0014-2999(90)90446-d (1990).","journal-title":"Eur. J. Pharmacol."},{"key":"70294_CR69","first-page":"735","volume":"60","author":"M Bujalska","year":"2008","unstructured":"Bujalska, M. & Gumulka, S. W. Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats. Pharmacol. Rep. 60, 735\u2013741 (2008).","journal-title":"Pharmacol. Rep."},{"key":"70294_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-2999(02)01413-9","volume":"441","author":"WA Prado","year":"2002","unstructured":"Prado, W. A., Schiavon, V. F. & Cunha, F. Q. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur. J. Pharmacol. 441, 57\u201365 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"70294_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0006-8993(01)01995-3","volume":"897","author":"AM Sousa","year":"2001","unstructured":"Sousa, A. M. & Prado, W. A. The dual effect of a nitric oxide donor in nociception. Brain Res. 897, 9\u201319. https:\/\/doi.org\/10.1016\/s0006-8993(01)01995-3 (2001).","journal-title":"Brain Res."},{"key":"70294_CR72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.niox.2011.06.004","volume":"25","author":"Y Cury","year":"2011","unstructured":"Cury, Y., Picolo, G., Gutierrez, V. P. & Ferreira, S. H. Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. Nitric. Oxide 25, 243\u2013254. https:\/\/doi.org\/10.1016\/j.niox.2011.06.004 (2011).","journal-title":"Nitric. Oxide"},{"key":"70294_CR73","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.bjp.0705181","volume":"138","author":"GG Vivancos","year":"2003","unstructured":"Vivancos, G. G., Parada, C. A. & Ferreira, S. H. Opposite nociceptive effects of the arginine\/NO\/cGMP pathway stimulation in dermal and subcutaneous tissues. Br. J. Pharmacol. 138, 1351\u20131357. https:\/\/doi.org\/10.1038\/sj.bjp.0705181 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"70294_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800254-4.00001-5","volume":"96","author":"A Bavencoffe","year":"2014","unstructured":"Bavencoffe, A., Chen, S. R. & Pan, H. L. Regulation of nociceptive transduction and transmission by nitric oxide. Vitam. Horm. 96, 1\u201318. https:\/\/doi.org\/10.1016\/B978-0-12-800254-4.00001-5 (2014).","journal-title":"Vitam. Horm."},{"key":"70294_CR75","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/628531","volume":"2014","author":"AR Park","year":"2014","unstructured":"Park, A. R., Lee, H. I., Semjid, D., Kim, D. K. & Chun, S. W. Dual effect of exogenous nitric oxide on neuronal excitability in rat substantia gelatinosa neurons. Neural Plast. 2014, 628531. https:\/\/doi.org\/10.1155\/2014\/628531 (2014).","journal-title":"Neural Plast."},{"key":"70294_CR76","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4103\/1673-5374.355748","volume":"18","author":"DY Li","year":"2023","unstructured":"Li, D. Y. et al. Targeting the nitric oxide\/cGMP signaling pathway to treat chronic pain. Neural Regen. Res. 18, 996\u20131003. https:\/\/doi.org\/10.4103\/1673-5374.355748 (2023).","journal-title":"Neural Regen. Res."},{"key":"70294_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","volume":"291","author":"AS Jaggi","year":"2012","unstructured":"Jaggi, A. S. & Singh, N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 291, 1\u20139. https:\/\/doi.org\/10.1016\/j.tox.2011.10.019 (2012).","journal-title":"Toxicology"},{"key":"70294_CR78","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41419-023-06227-8","volume":"14","author":"J Gomez-Deza","year":"2023","unstructured":"Gomez-Deza, J., Slavutsky, A. L., Nebiyou, M. & Le Pichon, C. E. Local production of reactive oxygen species drives vincristine-induced axon degeneration. Cell Death Dis. 14, 807. https:\/\/doi.org\/10.1038\/s41419-023-06227-8 (2023).","journal-title":"Cell Death Dis."},{"key":"70294_CR79","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.3390\/ijms16034600","volume":"16","author":"K Matsubara","year":"2015","unstructured":"Matsubara, K., Higaki, T., Matsubara, Y. & Nawa, A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int. J. Mol. Sci. 16, 4600\u20134614. https:\/\/doi.org\/10.3390\/ijms16034600 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"70294_CR80","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nn1876","volume":"10","author":"M Nagai","year":"2007","unstructured":"Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615\u2013622. https:\/\/doi.org\/10.1038\/nn1876 (2007).","journal-title":"Nat. Neurosci."},{"key":"70294_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11020093","author":"E Pozzi","year":"2023","unstructured":"Pozzi, E. et al. Paclitaxel, but not cisplatin, affects satellite glial cells in dorsal root ganglia of rats with chemotherapy-induced peripheral neurotoxicity. Toxics https:\/\/doi.org\/10.3390\/toxics11020093 (2023).","journal-title":"Toxics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70294-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:08:15Z","timestamp":1724166495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70294-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70294"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70294-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3837821\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F. L. is a co-founder and President of a startup company working on antisense oligonucleotide therapeutics. The rest of the authors do not have any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19341"}}